Answers are grounded in this paper and cite their sources.
Longitudinal evaluation demonstrates differential antibody and T-cell kinetics in vaccine recipients through eight months, highlighting distinct durability patterns between platforms.
To evaluate antibody and T-cell responses from peak immunity at 2 to 4 weeks after the second immunization in recipients of the messenger RNA (mRNA) vaccines or after the first immunization in recipients of the Ad26.COV2.S vaccine to 8 months.
No takes yet. Share an insight, caveat, or question.
A 2021 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: